BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 6099615)

  • 1. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change.
    Steen VM; Holmsen H
    Thromb Haemost; 1984 Dec; 52(3):333-5. PubMed ID: 6099615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC; Guccione MA; Packham MA; Mustard JF
    Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
    Antonikov IM; Alekseev OV; Chernukh AM
    Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine: possible role of platelet insensitivity to prostaglandin E1 (PGE1).
    Cerneca F; de Luyk S; Radillo O; Simeone R; Mangiarotti M
    Funct Neurol; 1993; 8(6):403-8. PubMed ID: 8150318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two distinct adenosine diphosphate receptors in human platelets.
    Colman RW; Figures WR; Colman RF; Morinelli TA; Niewiarowski S; Mills DC
    Trans Assoc Am Physicians; 1980; 93():305-16. PubMed ID: 6264660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenaline and adenosine diphosphate-induced platelet aggregation require shape change. Importance of pseudopods.
    Milton JG; Frojmovic MM
    J Lab Clin Med; 1984 Nov; 104(5):805-15. PubMed ID: 6387013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
    Kikura M; Kazama T; Ikeda T; Sato S
    Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of prostaglandins E1 and E2 in regulation of cyclic-AMP and aggregation in human platelets: evidence for a common prostaglandin receptor.
    McDonald JW; Stuart RK
    J Lab Clin Med; 1974 Jul; 84(1):111-21. PubMed ID: 4365532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of platelet cyclic nucleotide content by PGE1 and the prostaglandin endoperoxide PGG2.
    Miller OV; Gorman RR
    J Cyclic Nucleotide Res; 1976; 2(2):79-87. PubMed ID: 177467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of beta 2-glycoprotein-I upon the content of cAMP and cGMP in human blood platelets.
    Nimpf J; Gries A; Wurm H; Kostner GM
    Thromb Haemost; 1985 Dec; 54(4):824-7. PubMed ID: 3003956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired responsiveness of platelets from patients with stable angina pectoris to antiaggregating and cyclicAMP-elevating effects of prostaglandin E1.
    Chirkov YY; Chirkova LP; Sage RE; Horowitz JD
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):961-6. PubMed ID: 7564342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human platelet aggregation and cAMP system--cAMP level, adenyl cyclase, phosphodiesterase.
    Wang TY; Hussey CV; Sasse EA; Fobian JE
    Ann Clin Lab Sci; 1978; 8(5):403-12. PubMed ID: 213009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific inhibition of ADP-induced platelet aggregation by clopidogrel in vitro.
    Weber AA; Reimann S; Schrör K
    Br J Pharmacol; 1999 Jan; 126(2):415-20. PubMed ID: 10077233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
    Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of adenosine on levels of adenosine cyclic 3',5'-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation.
    Haslam RJ; Rosson GM
    Mol Pharmacol; 1975 Sep; 11(5):528-44. PubMed ID: 170501
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro effect of a thymic epithelial culture supernate or thymosin fraction 5 on rabbit platelet aggregation and intracellular cyclic AMP levels.
    Hashimoto S; Itoh Y; Kawaguchi A; Mizuno Y; Muraoka M; Tsuchiya M
    J Cell Physiol; 1987 Dec; 133(3):499-506. PubMed ID: 2826498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of the platelet activation sequence: shape change, micro- and macro-aggregation, by a stable prostacyclin analogue (Iloprost).
    Pedvis LG; Wong T; Frojmovic MM
    Thromb Haemost; 1988 Apr; 59(2):323-8. PubMed ID: 2455359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ADP-induced aggregation of human platelets by beta, gamma-methylene-ATP.
    Evans PM
    Cytobios; 1978; 23(90):101-8. PubMed ID: 158489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.